Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

29.67 UNCHANGED
Delayed Quote Updated: 7:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
News headline image
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Learn About the Securities Class Action Ahead of the November 2, 2026 Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
Breakthroughs in obesity, diabetes, oncology, and targeted therapies are driving fresh interest in peptide-based medicines and the companies developing the next generation of treatments. 
From FN Media
Via GlobeNewswire
News headline image
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:NVO),(NYSE:HIMS),(NYSE:ENHA),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
HIMS Deadline in 5 Days: Hims & Hers Health, Inc. Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline - Contact Kessler Topaz Meltzer & Check, LLP
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
Kaplan Fox Advises Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before the Deadline on November 2, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – HIMS
From Pomerantz LLP
Via GlobeNewswire
News headline image
HIMS URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors That Time Is Running Out to Lead the Securities Class Action - Deadline November 2, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Who Suffered Losses to Seek a Leadership Role Before November 2, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
1 unprofitable stock for long-term investors and 2 we avoid
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
Via StockStory
News headline image
HIMS Deadline: Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
HIMS Investor Alert: Hims & Hers Health, Inc. Stockholders with Large Losses Should Contact Robbins LLP About Leading the Class Action Lawsuit
San Diego, California--(Newsfile Corp. - October 23, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased... 
Via Newsfile
Topics Lawsuit
News headline image
Kaplan Fox Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of an Approaching Securities Class Action Deadline on November 2, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Hims & Hers Health, Inc. (NYSE: HIMS) Investors: Securities Class Action Deadline is November 2, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to an Upcoming Deadline of November 2, 2026 in the Securities Class Action
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – HIMS
From Pomerantz LLP
Via GlobeNewswire
News headline image
Kaplan Fox & Kilsheimer LLP Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors of a Securities Class Action and a November 2, 2026 Lead Plaintiff Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Hims Is Reaching the Three Million Member Milestone ↗
Several catalysts could sustain robust growth for Hims. 
Via The Motley Fool
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors of a Securities Class Action Lawsuit – Deadline is November 2, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Kaplan Fox & Kilsheimer LLP Announces a Securities Fraud Class Action Against Hims & Hers Health, Inc. (NYSE: HIMS) With a Lead Plaintiff Deadline of November 2, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.